NINTEDANIB vs TASIGNA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 15, 2026·How we rate

Possible drug interaction. NINTEDANIB and TASIGNA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NINTEDANIB	TASIGNA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NINTEDANIB	NILOTINIB HYDROCHLORIDE
Manufacturer	Teva Pharmaceuticals Development Inc	Novartis
Dosage forms	Capsule	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Idiopathic Pulmonary Fibrosis	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

nintedanib tasigna

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

NINTEDANIB

NILOTINIB HYDROCHLORIDE

Manufacturer

Teva Pharmaceuticals Development Inc

Novartis

Dosage forms

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Idiopathic Pulmonary Fibrosis

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

Frequently asked questions

What is the difference between Nintedanib and Tasigna?

Nintedanib contains Nintedanib, while Tasigna contains Nilotinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.